Cell Therapy Development

Functional Molecules

Functional Polymer

Bioengineering

Material Chemistry

Leveraging the power of induced pluripotent stem cells (iPSCs) for cell therapies has the potential to fulfill unmet medical needs.

Innovation designed to address diseases

Every day patients worldwide are diagnosed with diseases with few treatment options available. While many existing therapies aim to stop disease progression and silence symptoms, we don’t think that's enough.

FUJIFILM Cellular Dynamics Inc. is working to improve today’s therapies to address unmet needs and improve how patients are treated. We are focused on developing off-the-shelf allogeneic cell therapy candidates in the areas of ocular diseases, heart failure, immuneoncology and Parkinson’s disease.

We continue to make critical investments in enhancing cell therapy efforts including the opening of our 32,000 square-foot cell therapy cGMP manufacturing facility in Madison, Wisconsin. Opsis Therapeutics, is a new a joint venture focused on regenerative medicine therapies, including macular degeneration, retinitis pigmentosa and cone dystrophies.

Looking ahead, we will expand cell therapy development, an unprecedented opportunity to participate in the front ranks of a revolution in treating diseases with unmet needs.